Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

Find out all you need to know about Ozempic and other weight loss drugs, including the dangers and side effects ...

If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...

Rybelsus is approved along with a diet and exercise plan to manage blood sugar levels and type 2 diabetes. Some people use it off-label for weight loss. Limiting overly processed foods ...

Other brand names for semaglutide you might have heard of include Wegovy (a higher-dose semaglutide injection FDA-approved for weight loss) and Rybelsus (a tablet form of semaglutide FDA-approved ...

Retatrutide — an experimental drug nicknamed “triple G” — could be your best shot at a slimmer waistline when it becomes available to the public, a Monday study found. Obese adults who ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

including Rybelsus, another drug that works to combat diabetes and can lead to weight loss; Trelegy Ellipta, which treats chronic obstructive pulmonary disease and asthma; and Xtandi, which treats ...